This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Closed Joint Stock Company “Biocad”, Other. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Puschino Moskovskaya obl., RU (2019)
- Puschino, RU (2019 - 2022)
Company Filing History:
2 out of 2 
1 out of 834,659 Years Active: 2019-2022
Title: Valeriy Vladimirovich Soloviev: Innovator in Monoclonal Antibodies
Introduction
Valeriy Vladimirovich Soloviev is a notable inventor based in Puschino, Russia. He has made significant contributions to the field of medicine, particularly in the development of monoclonal antibodies. With a total of 3 patents, his work focuses on innovative methods for treating IL-17A-mediated diseases.
Latest Patents
One of his latest patents is a method for the treatment of an IL-17A-mediated disease through antibody administration specific to human IL-17A. This invention involves monoclonal IgG-type antibodies that comprise variable domains represented by a combination of VHH-derivative with a variable domain of the light chain V. The antibodies suggested in this patent possess increased affinity and improved aggregation stability due to amino acid substitutions at specific positions. Another significant patent relates to anti-IL-17 antibodies, which are designed to bind with high affinity to an IL-17 epitope. These antibodies can be chimeric, humanized, or human antibodies, and they are intended for use as medicinal agents in treating autoimmune and inflammatory disorders.
Career Highlights
Throughout his career, Valeriy has worked with various organizations, including the Closed Joint Stock Company “Biocad.” His expertise in the field of monoclonal antibodies has positioned him as a key figure in medical research and innovation.
Collaborations
Valeriy has collaborated with notable professionals in his field, including Stanislav Rudolfovich Evdokimov and Olga Vladimirovna Goncharova. These collaborations have further enhanced his contributions to the development of advanced medical treatments.
Conclusion
Valeriy Vladimirovich Soloviev is a distinguished inventor whose work in monoclonal antibodies has the potential to significantly impact the treatment of various diseases. His innovative approaches and collaborations continue to advance the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile